Exact Mass: 412.135775
Exact Mass Matches: 412.135775
Found 147 metabolites which its exact mass value is equals to given mass value 412.135775,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-Methylamino-4-de(dimethylamino)anhydrotetracycline
Methylpicraquassioside A
C19H24O10 (412.13694039999996)
Methylpicraquassioside A is found in herbs and spices. Methylpicraquassioside A is a constituent of Ruta graveolens (rue). Constituent of Ruta graveolens (rue). Methylpicraquassioside A is found in herbs and spices.
O-Deethylated candesartan
O-Deethylated candesartan is only found in individuals that have used or taken Candesartan.O-Deethylated candesartan is a metabolite of Candesartan. O-deethylated candesartan belongs to the family of Biphenyltetrazoles and Derivatives. These are organic compounds containing a biphenyl attached to a tetrazole. A carbon atom of the biphenyl moiety is boned to a carbon or the nitrogen atom of the tetrazole moiety.
(2S,3S,4S,5R)-6-(Benzo[b][1]benzazepine-11-carbonylamino)-3,4,5-trihydroxyoxane-2-carboxylic acid
Capmatinib
C23H17FN6O (412.14478039999995)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
N6-Threonylcarbamoyladenosine
CONFIDENCE standard compound; INTERNAL_ID 308
4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-1,12-dioxo-2-naphthacenecarboxamide
8-deacetylcentaurepensin-8-O-(4-hydroxy)tiglate|8-deacylcentaurepensin 8-O-(4-hydroxy)-tiglate|8-desacetylcentaurepensin-8-O-(4-hydroxytiglinate)
(S)-2-amino-5-((R)-1-carboxy-2-((E)-3-(4-hydroxy-3-methoxy-phenyl)allylthio)ethyl-amino)-5-oxopentanoic acid|N-L-gamma-glutamyl-S-coniferyl-L-cysteine
8alpha,13-diacetoxy-1alpha,10alpha-1beta,5beta-diepoxygermacra-7(11)en-12-olide
C19H24O10 (412.13694039999996)
5-Benzofuranpropanoic acid, 6-(beta-D-glucopyranosyloxy)-7-methoxy-, methyl ester
C19H24O10 (412.13694039999996)
(1R,3S,4S,5S,6S,7R,8S)-4beta-(chloromethyl)-3beta,4alpha-dihydroxy-8alpha-(sarracenoyloxy)-1alphaH,5alphaH,6betaH,7alphaH-guai-10(14),11(13)-dien-6,12-olide
4,7-dimethoxy-3,5-dimethyl-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
C19H24O10 (412.13694039999996)
C19H24O10_5-Benzofuranpropanoic acid, 6-(beta-D-glucopyranosyloxy)-7-methoxy-, methyl ester
C19H24O10 (412.13694039999996)
Ala Cys Gly Tyr
Ala Cys Tyr Gly
Ala Gly Cys Tyr
Ala Gly Tyr Cys
Ala Tyr Cys Gly
Ala Tyr Gly Cys
Cys Ala Gly Tyr
Cys Ala Tyr Gly
Cys Phe Gly Ser
Cys Phe Ser Gly
Cys Gly Ala Tyr
Cys Gly Phe Ser
Cys Gly Ser Phe
Cys Gly Tyr Ala
Cys Ser Phe Gly
Cys Ser Gly Phe
Cys Tyr Ala Gly
Cys Tyr Gly Ala
Phe Cys Gly Ser
Phe Cys Ser Gly
Phe Gly Cys Ser
Phe Gly Ser Cys
Phe Ser Cys Gly
Phe Ser Gly Cys
Gly Ala Cys Tyr
Gly Ala Tyr Cys
Gly Cys Ala Tyr
Gly Cys Phe Ser
Gly Cys Ser Phe
Gly Cys Tyr Ala
Gly Phe Cys Ser
Gly Phe Ser Cys
Gly Ser Cys Phe
Gly Ser Phe Cys
Gly Tyr Ala Cys
Gly Tyr Cys Ala
Ser Cys Phe Gly
Ser Cys Gly Phe
Ser Phe Cys Gly
Ser Phe Gly Cys
Ser Gly Cys Phe
Ser Gly Phe Cys
Tyr Ala Cys Gly
Tyr Ala Gly Cys
Tyr Cys Ala Gly
Tyr Cys Gly Ala
Tyr Gly Ala Cys
Tyr Gly Cys Ala
O-Deethylated candesartan
Methylpicraquassioside A
C19H24O10 (412.13694039999996)
T6A [ABBR]
cobalt,(6Z)-6-[[3-[methyl-[3-[[(E)-(6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]propyl]amino]propylamino]methylidene]cyclohexa-2,4-dien-1-one
4-(Benzyloxy)-6-[(benzyloxy)carbonyl]-2-naphthoic acid
Nizofenone
C21H21ClN4O3 (412.13021060000005)
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents
FMoc-(R)-3-AMino-3-(4-cyano-phenyl)-propionic acid
C25H20N2O4 (412.14230000000003)
FMOC-(S)-3-AMINO-3-(4-CYANO-PHENYL)-PROPIONICACID
C25H20N2O4 (412.14230000000003)
(tert-butoxycarbonylmethyl)triphenylphosphonium chloride
C24H26ClO2P (412.13588560000005)
DMP 543
C26H18F2N2O (412.13871219999993)
3-(4-Butoxyphenyl)-7-phenylfuro[2,3-f][1]benzofuran-2,6-dione
4-Methoxyphenyl beta-D-galactopyranoside 2,4,6-triacetate
C19H24O10 (412.13694039999996)
O-Desethyl Candesartan
A benzimidazolecarboxylic acid that is candesartan in which the ethoxy group has been replaced by a hydroxy group. It is the inactive metabolite of the anti-hypertensive drug, candesartan.
[(2S)-2-Sulfanyl-3-phenylpropanoyl]-gly-(5-phenylproline)
C22H24N2O4S (412.14567040000003)
Capmatinib
C23H17FN6O (412.14478039999995)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
(4S,4aS,12aS)-3,10,11,12a-tetrahydroxy-6-methyl-4-(methylamino)-1,12-dioxo-4a,5-dihydro-4H-tetracene-2-carboxamide
1-Benzyl-5-(3,5-dimethylpiperidin-1-yl)sulfonylindole-2,3-dione
C22H24N2O4S (412.14567040000003)
3-methyl-2-benzo[g]benzofurancarboxylic acid [2-[N-(2-cyanoethyl)anilino]-2-oxoethyl] ester
C25H20N2O4 (412.14230000000003)
2-[[5-(3-aminophenyl)-4-methyl-1,2,4-triazol-3-yl]thio]-1-(9H-fluoren-2-yl)ethanone
Ethyl 4-amino-2-[[4-amino-6-(4-methylanilino)-1,3,5-triazin-2-yl]methylsulfanyl]pyrimidine-5-carboxylate
2-[(2-tert-butyl-4-quinazolinyl)thio]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide
C21H24N4OS2 (412.13914539999996)
1,1,2,2,3,3,4,4,5,5-Decamethyl-1,5-bis((methylthio)methyl)pentasilane
(1S,5R)-7-[4-(2-fluorophenyl)phenyl]-3-[(1-methyl-4-imidazolyl)sulfonyl]-3,6-diazabicyclo[3.1.1]heptane
[(1R,2aS,8bS)-1-(hydroxymethyl)-4-(3-methylphenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-cyclopropylmethanone
C22H24N2O4S (412.14567040000003)
[(1S,2aR,8bR)-1-(hydroxymethyl)-4-(3-methylphenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-cyclopropylmethanone
C22H24N2O4S (412.14567040000003)
(6S,7S,8R)-4-(benzenesulfonyl)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C22H24N2O4S (412.14567040000003)
(6R,7S,8R)-4-(benzenesulfonyl)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C22H24N2O4S (412.14567040000003)
[(2R,3R)-1-(benzenesulfonyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-cyclopropylmethanone
C22H24N2O4S (412.14567040000003)
[(1R,2aR,8bR)-1-(hydroxymethyl)-4-(3-methylphenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-cyclopropylmethanone
C22H24N2O4S (412.14567040000003)
(6R,7R,8R)-4-(benzenesulfonyl)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C22H24N2O4S (412.14567040000003)
(6S,7S,8S)-4-(benzenesulfonyl)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C22H24N2O4S (412.14567040000003)
(6S,7R,8S)-4-(benzenesulfonyl)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C22H24N2O4S (412.14567040000003)
(6R,7R,8S)-4-(benzenesulfonyl)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C22H24N2O4S (412.14567040000003)
(6R,7S,8S)-4-(benzenesulfonyl)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C22H24N2O4S (412.14567040000003)
[(2S,3S)-1-(benzenesulfonyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-cyclopropylmethanone
C22H24N2O4S (412.14567040000003)
[(2S,3R)-1-(benzenesulfonyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-cyclopropylmethanone
C22H24N2O4S (412.14567040000003)
4,7-dimethoxy-3,5-dimethyl-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
C19H24O10 (412.13694039999996)
N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonine
An N-(adenosin-N(6)-ylcarbonyl)threonine in which the threonine portion has L-configuration.
desmethylanhydrotetracycline zwitterion
A zwtterion obtained by transfer of a proton from the 2-hydroxy to the secondary amino group of desmethylanhydrotetracycline. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
desmethylanhydrotetracycline
A member of the class of tetracyclines that is anhydrotetracycline in which one of the methyl groups attached to the nitrogen has been replaced by hydrogen.
NSC45586 (sodium)
C20H17N6NaO3 (412.12597719999997)
NSC45586 sodium is an inhibitor of pleckstrin homology domain and leucine-rich repeat protein phosphatase (PHLPP). NSC45586 sodium targets the PP2C phosphatase domain in PHLPP1 and PHLPP2. NSC45586 sodium can activate AKT in neurons[1].